Tag Archive | "stocks"

Tags: , , , , , , , , , , , , , , , , , , , ,

Vaporin Inc – VAPO


Vaporin – The Premier Electronic Cigarette

Vaporin offers an exciting new smoking alternative for the smokers. Vaporin Electronic Cigarettes resemble traditional cigarettes in look, taste and feel. It’s easy to use, runs on a rechargeable battery and lights up automatically. Users inhale their desired amount of nicotine through the option of numerous delicious flavors. The thing that distinguishes Vaporin vs. traditional cigarettes is, each drag consists of smoke vapors, leaving no ash or butts behind.

Vaporin is always changing the electronic cigarette industry standard, and continues to be the leader the ecig branding, marketing and customer service. Vaporin is constantly growing as America’s most trusted brand of electronic cigarette for the following reasons:

  • Quality: Vaporin’s e-cigarettes are made with the highest quality
  • Branding and Marketing: Vaporin always comes up with new promotions and unique marketing approaches
  • Customer Service and Support: Vaporin’s customer service support team will always go out of their way to make sure our customers are 100% satisfied
  • Warranty: Vaporin offers a 30 day money back guarantee and also a lifetime warranty to loyal customers

Vaporin Electronic Cigarettes Offer A Plethora Of Advantages Over Traditional Cigarettes:

  • Rated as the best electronic cigarette available on the market
  • Maximizes volume of smoke vapor
  • User friendly
  • Control over the taste.
  • Free from tar
  • No ash is left behind
  • Free from Carbon Monoxide
  • No fire hazards
  • Free from offensive odors sticking to cars, walls, linen, or clothing
  • Free from smoker’s breath.
  • Cost effective as compared to traditional cigarettes.
  • Legally allowed in the areas like restaurants, bars, airports and other places where smoking is banned
  • Free from polluting cigarette butts

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , ,

Analytica Bio-Energy Corp. – ABEC


The manufacturing industry has taken dramatic shifts from traditional methods of manual operations. To keep with the ever changing times manufactures have moved into technology operated empires. With change come new obstacles. Automated and mass production in the majority of manufacturing produces more wastewater.

Industrial Wastewater in itself is a hazardous substance. Toxic chemicals cannot be disposed of into sewers, rivers, or lakes. When left unchecked these chemicals destroy all life form in the waterways, plus endup in the water we drink..

Analytica Bio-Energy Corp. has developed new patented technology; technology that removes all toxic and hazardous chemicals prior to disposal.

Analytica’s equipment manufacturing process undergoes continuous and rigorous scrutiny during manufacturing, and assembly, Quality control inspections, and our highly trained and experienced work force insures the highest quality start to finish.

Analytica Bio-Energy Corp has developed and patented the new NH3-N Wastewater Treatment System that removes all toxic and hazardous chemicals prior to disposal! This system combines ultrafiltration equipment, microfiltration, reverse osmosis equipment, EDI equipment and other combinations.

As the world population grows and the rapid development of industrial agricultural production increases, complex chemical substances are introduced into the water, contaminating the water. It was realized that the role of NH3-N eutrophication, the wastewater treatment developed to target the removal of organic matter and ammonia was essential.
New NH3-N wastewater treatment system combines ultrafiltration equipment, microfiltration, reverse osmosis equipment, EDI equipment and other combinations developed a new system, namely-NH3-N wastewater solutions.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

Chelsea Oil and Gas Ltd. – COGLF


Chelsea Oil & Gas is an Australian focused exploration, development and production company. We have a significant portfolio of assets onshore Australia comprised of 5.2 million net acres across four basins:

Each basin offers stacked pay, and the South Georgina, Simpson and Surat Bowen Basins offer billion barrel unconventional resource potential. With up to $545 million of investment on offsetting lands in the next three years by Supermajors, and a low cost program targeting more than 1.0 billion barrels of unrisked prospective resources, Chelsea is well positioned to create significant near-term value for its shareholders.

Corporate Highlights

1) Large, Operated, High Working Interest Resource Base
  • Average 84% operated working interest in 6.2 million acres (5.2 million net) onshore Australia
  • High impact potential in Georgina and Simpson Basins with 3.5 billion barrels recoverable resources
  • Control of the preparation of budgets and schedules facilitates the delivery of value creation strategy
2) Near-Term Path to Value Realization
  • Opportunity set across portfolio defined through seismic, drilling on offsetting acreage and analogues
  • Near-term oil production and existing overriding royalty cashflow offsets G&A

3) Low-Cost, High-Impact Assets Near Existing Infrastructure

  • Offsetting exploration currently underway by Statoil, Total and Santos committing up to $545 million
  • Gas infrastructure less than 150 km from unconventional permit; well established paved roadways and rail network nearby all permits
  • Limited near-term capex required to maintain asset base means the large investment necessary to evaluate the basin’s unconventional resource will be made by off-setting super-majors.

4) Catalyst Rich Exploration and Development Programme

  • Carried for up to 6 exploration wells and 120 km2 of 3D seismic in 2013 / 14 (Cooper Basin)
  • 2 production wells in 2014 targeting 300 bopd 51°oil from existing discoveries (Surat Basin)
  • Additional exploration and development targets to be matured through work programme

5) Favourable Political, Fiscal and Operating Environment

  • Australia has leading Western fiscal regime: 10% state royalty, 30% corporate tax
  • Queensland most active onshore exploration and production state, well serviced by oilfield industry
  • Local demand for oil and gas, LNG export potential for significant discoveries
  • Stable political outlook with investment grade debt rating of Aaa by Moody’s

6) Experienced Board and Management

  • 125+ years of industry experience among directors and senior management
  • Direct experience in horizontal multi-stage frac and unconventional drilling
  • Direct experience with enhanced and secondary recovery techniques

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , ,

Radiant Creats Group INC – RCGP


The Radiant Creations Group (Radiant) (Trading Symbol-RCGP) develops and markets unique and proprietary cosmetic and over the counter products. These products use both new technologies and ingredients, such as herbal extracts from the centuries of proven Traditional Chinese Medicine. Dr. Yin-Xiong Li, M.D. Ph.D., world-renowned geneticist and a Chief Medical Officer in China, is the chief scientific advisor to Radiant, and has developed or enhanced most of the company’s products. Radiant acquired an exclusive license agreement for Dr. Li’s patented and trade secret technologies; a patent for “Enhanced Broad – Spectrum UV Radiation Filters and Methods” an improvement application for DNA protection from UV radiation, an anti-aging skin rejuvenation cream, an acne over-the-counter treatment, a wrinkle reduction cream, and nutritional supplements for BioSalt redistribution technology for liver health, hypertension, and weight control. The recent asset transaction included the transfer of the licensing agreement, inventory, and other related intellectual property from The Renewable Corporation.

The comprehensive asset acquisition includes innovative technologies in skin protection from the sun, industrial UV sources (such as welding), and reducing collateral damage from medical radiation treatment. The patented technology strips out the four nucleotide code molecules from DNA strands and uses them in a system that can provide up to 99% protection from DNA damage from high energy UV light, which is the major cause of aging and skin cancer.

The harmful effects of sunburn are well known, but exposure to the UV radiation in sunlight does more than just damage the surface of the skin. DNA damage, such as free radicals, oxidative stress, and mutational changes can lead to cancer and other serious conditions. Many sunscreen products currently in use do not provide sufficient protection; in fact, some contain ingredients that break down under UV radiation and form chemicals that actively damage the skin. With dangerous new levels of UV-B radiation now reaching the surface of the earth due to atmospheric damage, the risk of radiation exposure has increased exponentially. In addition, the technology can be used for increased protection in the workplace, in medical treatment radiation exposure to Beta and Gamma rays, and other opportunities in the industrial and architectural markets.

A second technology is the delivery system to house the nucleotides, and also a hydration agent that is time released to infuse uniform hydration in the skin for up to 10 hours. The enhanced skin hydration level “off loads” the skin’s repair mechanisms, freeing them to work on repairing other imperfections, resulting in significant anti-aging and rejuvenation benefits.

The resulting products from these two technologies are a nucleotide based SPF-30 sunblock; an anti-aging and rejuvenating cream featuring the hydration system, Chinese herbs, and aloe; a medical radiation protection and healing cream for use by dermatologists in radiation therapy for skin cancer, and a rejuvenating nucleotide protection cream for the tanning bed industry, for DNA damage protection. The asset acquisition allows Radiant to capitalize on multiple scientific breakthroughs with remarkable potential. These exciting discoveries for skin care are branded as the “Revivasol” skin care line.

A second product line is BioSalts, an innovative product line for the dietary supplement market. The BioSalts products have been formulated using an exclusive combination of natural Chinese herbal ingredients with advanced technologies utilizing molecular elements that help regulate energy homeostasis to promote various positive health benefits such as fat burning, weight loss, weight control, increased energy, enhanced sleep, tissue regeneration and lower blood pressure. The technology as a supplement also promotes liver health.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , ,

Liberated energy Inc – LIBE


Liberated Energy, Inc.’s initial objective is to make small wind and solar turbine technology a significant contributor to the global clean energy supply portfolio by providing consumers with an affordable renewable energy option for their homes and businesses.

  • Liberated’s patent pending technology should offer every homeowner the opportunity to generate the majority of his or her monthly electrical requirements.
  • Liberated’s technology will be more affordable than any existing wind and solar options currently available.
  • Because of Liberated’s innovative design, the turbine and housing will be aesthetically pleasing and will tie in with existing architecture.

Liberated Energy, Inc. has recently acquired Perpetual Wind Power Corporation (PWPC). PWPC has applied for a U.S. patent…Patent Application Serial No. 61/27,578 through Woodcock Washburn, a national law firm specializing in intellectual property law (www.woodcock.com).

Wind Energy Potential

  • According to the Department of Energy, wind power costs dropped by 80% between 1984 and 2004.
  • Current energy costs (coal, nuclear and natural gas) are projected to increase approximately 10% annually.
  • Wind power has no fuel costs and low or negligible costs for maintenance compared to current energy sources.
  • The main reason why the growth of wind power is lagging in the U.S. is not lack of demand, but lack of supply. There is no reason why the U.S. could not only make wind turbines for its own need, but become a wind turbine exporter, creating jobs.*

*Watson, John, Ehow.com, Cost Benefits Wind Energy.

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , ,

Puget Technologies Inc – PUGE


Puget Technologies is growing fast and working hard to ensure maximum returns for its shareholders. The board of directors and management of Puget Technology are committed to establishing and encouraging a conscientious business environment and always operating in a responsible and ethical manner. Puget only works with top-rated, reputable companies. Puget Technologies firmly believes this commitment, along with sound management practices, is the cornerstone to maintaining the trust of its investors, employees and consumers. Puget’s business practices are reflective of the requirements of applicable securities laws and stock exchange requirements.
Puget Technologies mission is to develop the company’s presence throughout the United States by:
  • Partnering with companies which offer leading edge consumer oriented products and technologies, and taking them to the next level.
  • Conducting product research and development that will result in the commercialization of well-manufactured, forward-looking products.
  • Offering consumers improved and/or more versatile options over existing products.
  • Offering our products to consumers in a responsible manner.
  • Maintaining the highest ethical standards in all business endeavors.
Puget Technologies vision is to become a leader in each of the industries in which it is involved by responsibly delivering quality, innovative products to consumers.

Cannabis Biotech, a wholly owned subsidiary of Puget Technologies ( OTC: PUGE ), is a forward thinking publicly held company dedicated to the development of patented and proprietary health, wellness and medical grade cannabinoid products.

http://www.cannabisbiotech.com/wp-content/uploads/2013/10/about1.jpg

Cannabis Biotech conducts cutting edge research to develop innovative cannabinoid products and therapies for the treatment of diseases and their symptoms including HIV, cancer, glaucoma and neurological disorders.

An increasing number of states in the U.S. and numerous countries have legalized or recognized the use of cannabinoid products and treatments, changing public attitudes as science demonstrates the benefits for the products in the management of certain diseases and conditions.

Headquartered in Ft. Lauderdale, Florida, Cannabis Biotech is led by Ron Leyland, who has demonstrated ability to identify trends, generate new products, produce and develop branding for individual products and product lines, create innovative sales and distribution strategies domestically and internationally, while maintaining the highest standards.

Visit their website : http://www.cannabisbiotech.com/

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

Cablevision swings to third-quarter profit


Cablevision Systems Corp. CVC -2.11% swung to a third-quarter profit as the cable operator reported higher revenue, though customer rolls shrank.

While Cablevision maintains a high penetration of video, broadband and voice services in its main coverage area around New York City, it has faced increased competition in its own backyard from telecommunications peers, such as Verizon Communications Inc.’s (VZ) fiber-optics services, as well as streaming-video services like Netflix Inc. (NFLX).

Cablevision this year sought to sharpen its focus on its core market, agreeing to sell the western cable system it bought just a few years ago to Charter Communications Inc. (CHTR) for $1.6 billion. The move helped Cablevision to maintain one of its strengths of being regionally clustered, which has allowed it to be efficient in marketing and in deploying services like digital cable and cloud-based digital video recording faster than other cable operators.

Also, in April Bow Tie Cinemas agreed to buy all of the Clearview Cinemas theaters from Cablevision.

The Long Island-based company reported it lost 37,000 video customers, 18,000 voice subscribers and 13,000 high-speed data customers since the second quarter.

Total customers reached 3.2 million, down 29,000 from the second quarter.

Overall, Cablevision reported a profit of $294.6 million, or $1.10 a share, compared with a year-earlier loss of $3.8 million, or a penny a share. The year-ago period included losses on extinguishment of debt and certain write-offs of $61.1 million, compared with similar losses of $16.5 million in the latest period. Per-share earnings from continuing operations, which exclude its western cable system and Clearview, rose to 22 cents from a penny.

Revenue grew 1.8% to $1.57 billion.

Analysts polled by Thomson Reuters were looking for a per-share profit from continuing operations of 11 cents on $1.57 billion in revenue.

Shares closed Thursday at $15.63 and were inactive premarket. The stock has risen 4.6% so far this year.

Write to Ben Fox Rubin at ben.rubin@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires

SOURCE: http://www.marketwatch.com/story/cablevision-swings-to-third-quarter-profit-2013-11-08-104851148

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Readen Holding Corp – RHCO


Readen Holding Corp, a Venture Capital organisation,investor and shareholder of companies operating in hree separate industries. Readen Holding Corp. has access to an extensive, influential and loyal network of business relations and investors.

Readen Group’s mission statement is to be a valuable partner for customers in terms of technical flexibility, quality and competitive pricing through the complete value chain (SIM cards, mobile phones and applications).

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , , ,

AppTech Corp. (APCX)


AppTech Corp. (APCX) is an information technology and financial services company.

With electronic payments at its core, the company offers an array of service lines to both business and consumer markets through its branded subsidiaries, Transcendent One and TransTech One.

Overall strategy is simple. Acquire merchant services and develop merchant services channels.

AppTech Corp has also developed a patented mobile technology strategy to succeed in the growing mobile payments industry.

Through its subsequent joint ventures and acquisitions, the company will complement its current product channels and continue its growth as a technology and finance leader.

The company is currently seeking capital between $5MM and $10MM to accomplish the following growth initiatives in the immediate future:

a) Increase merchant services production and bolster operations (including increased processing reserves)

b) Increase TransTech One Retail Service Center locations to support energy client contracts (authorized payments) and capture new regional markets for IT services and merchant services

c) Activate contracts at JV level and launch associated merchant services platforms

d) Launch and deploy patented mobile technologies with licensing model

e) Launch and market ecommerce products (i.e. ‘Credit Into Cash’ and other consumer and business payment products) APCX stock needs support between $2 and $4 per share as anagement executes the aforementioned growth initiatives. Within 12 months of completed $10MM financing, the company will attain a run rate of approximately $25MM per month, resulting in significant net earnings of 15% and reflect a stock price between $10 and $15 per share.

3 Months from Completed $2MM Financing

- Increased ACH processing reserves resulting in monthly revenue increase by over 15% per month

- 5 TransTech One Retail Service Centers opened and operating

- Launched mobile IP strategy with joint ventures into marketplace with products and licensing

- All registrations for market uplisting and audits in process if not already completed

6 Months from Completed $5MM Financing

- 15 TransTech One Retail Service Centers opened and operating resulting in $2.25MM per month in gross revenue

- Launched several ecommerce joint ventures resulting in increased processing revenue

- Continued growth and increased revenue from processing and IP licensing model

12 Months from Completed $10MM Financing

- 25 TransTech One Retail Service Centers opened and operating resulting in $3.75MM per month in gross revenue

- Acquisition of additional synergistic IP & operating companies already in development

- Release of additional software technologies already in development (consumer and business payment products)

Posted in Featured, Stock NewsComments Off

Tags: , , , , , , , , , , , , , , , , , , , , , , , ,

E-Waste Systems, Inc – EWSI


E-Waste Systems, Inc. (OTCQB:EWSI), through its subsidiaries and affiliates, offers customized end-to-end solutions in IT Asset Recovery, E-Waste Management, and Electronics Reverse Logistics.

Leveraging its affiliates’ complementary geographies, technical capabilities, and strong supplier relationships, EWSI expands the services offered to customers, cross-fertilizes best management practices, streamlines logistics, aggregates volumes, and invests in cutting-edge recycling technologies.

Their Focus:

  • Leadership in safe, compliant, and ethical e-waste disposal
  • Global delivery of services
  • Application of state-of-the-art technology and engineering
  • Posted in Featured, Stock NewsComments Off

    Advertise Here